Sanofi Expands Immunization Footprint With $2.2 Billion Dynavax Acquisition
Sanofi agrees to acquire vaccine maker Dynavax for $2.2 billion in cash, strengthening its adult immunization portfolio and pipeline growth.
364 views
•
5 months ago